PDB32 EVALUATING THE LONG-TERM CLINICAL AND ECONOMIC IMPLICATIONS OF CONVERTING TYPE 2 DIABETES PATIENTS TO INSULIN DETEMIR (±ORAL HYPOGLYCEMIC AGENTS) FROM INSULIN GLARGINE BASED REGIMENS IN GERMANY; DATA FROMTHE PREDICTIVE STUDY
Nov 1, 2007, 00:00
10.1016/S1098-3015(10)64980-7
https://www.valueinhealthjournal.com/article/S1098-3015(10)64980-7/fulltext
Title :
PDB32 EVALUATING THE LONG-TERM CLINICAL AND ECONOMIC IMPLICATIONS OF CONVERTING TYPE 2 DIABETES PATIENTS TO INSULIN DETEMIR (±ORAL HYPOGLYCEMIC AGENTS) FROM INSULIN GLARGINE BASED REGIMENS IN GERMANY; DATA FROMTHE PREDICTIVE STUDY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)64980-7&doi=10.1016/S1098-3015(10)64980-7
First page :
Section Title :
Open access? :
No
Section Order :
139